Scancell Holdings Plc
2 known investors
Find your way into Scancell Holdings Plc
67 people in our graph share verified history with the Scancell Holdings Plc team — schools, employers, funds. One of them is your warm intro.
Anne Horganunlockedknows Phil L'Huillier · together at Cancer Research Technology Limited (overlapped)
×5knows the team · via Msd
×3knows the team · via CatalYm
knows the team · via Artios Pharma
×2knows the team · via The University of Waikato
Scancell is a late-stage clinical biotechnology company developing active immunotherapies to strengthen anti-tumor immune responses in hard-to-treat cancers. Its treatments are built on its proprietary Immunobody and Moditope platforms.
Founders & leadership
PL
Professor Lindy DurrantCo-founder & Chief Scientific Officer
PL
Phil L'HuillierinChief Executive OfficerCEO of Scancell Holdings, a clinical-stage biotechnology company developing immunotherapies for solid tumors. Brings background in biotechnology and pharmaceutical leadership, corporate development, and clinical development.
DS
David SchilanskyInterim Chief Financial Officer
DN
Dr Nermeen VarawallaChief Medical Officer
Board
DJ
Dr Jean-Michel CosséryNon-Executive Chairman
Investors · 2
In the news
Frequently asked questions
- What does Scancell Holdings Plc do?
- Scancell is a late-stage clinical biotechnology company developing active immunotherapies to strengthen anti-tumor immune responses in hard-to-treat cancers. Its treatments are built on its proprietary Immunobody and Moditope platforms.
- Who founded Scancell Holdings Plc?
- Scancell Holdings Plc was founded by Professor Lindy Durrant.
- Who are Scancell Holdings Plc's investors?
- Scancell Holdings Plc's investors include Seneca Partners, BlackRock.